Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Structural change of biopharmaceuticals using ion mobility mass spectrometry analysis
- In: Posters A - Analytical Sciences and Pharmaceutical Quality
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PA-002
- By: KAMADA, Haruhiko (National Institute of Biomedical Innovation, Laboratory of Biopharmaceutical Research, Ibaraki,, Japan)
- Co-author(s): Inoue (National Institute of Biomedical Innovation, Ibaraki,, Japan)
Nagano (National Institute of Biomedical Innovation, Ibaraki,, Japan)
Mukai (National Institute of Biomedical Innovation, Ibaraki,, Japan)
Higashisaka (Osaka University, Suita, Japan)
Yoshioka (Osaka University, Suita, Japan)
Tsutsumi (Osaka University, Suita, Japan)
Tsunoda (National Institute of Biomedical Innovation, Ibaraki,, Japan) - Abstract:
Protein misfolding could in many cases underlie the immunogenicity of biopharmaceuticals. Conformational changes of biopharmaceuticals can also affect their potency because the correct structure is important for binding and signal transduction. Ion mobility mass spectrometry (IM-MS), which can separate different-sized molecules with an ion..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023